<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href='static/style.xsl' type='text/xsl'?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-22T11:08:19Z</responseDate><request verb="GetRecord" identifier="oai:ecommons.cornell.edu:1813/117134" metadataPrefix="dim">https://ecommons.cornell.edu/server/oai/request</request><GetRecord><record><header><identifier>oai:ecommons.cornell.edu:1813/117134</identifier><datestamp>2026-05-15T19:51:38Z</datestamp><setSpec>com_1813_35</setSpec><setSpec>col_1813_47</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="author">Gupta, Shagun</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="chair" lang="en_US">Yu, Haiyuan</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember" lang="en_US">Booth, James</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember" lang="en_US">Mezey, Jason</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember" lang="en_US">Smolka, Marcus</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2025-06-30T22:02:48Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2025-06-30T22:02:48Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2024-12</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other">ProQuest Submission ID: 14728</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other">ProQuest Publication ID: 31639469</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://hdl.handle.net/1813/117134</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="doi">http://doi.org/10.7298/77yj-8w97</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="bibid">16921875</dim:field>
   <dim:field mdschema="dc" element="description" lang="en_US">217 pages</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">Quantitative proteomics offers transformative insights into molecular mechanisms underlying complex diseases; however, the inherent noise and variability in proteomic data pose significant challenges for accurate signal detection. This led to the development of the Maximal Aggregation of Good protein signal from Mass spectrometric data (MAGMa) tool, which leverages rigorous statistical testing to achieve a balance between sensitivity and specificity, effectively filtering out noise and enabling robust identification of subtle, true biological signals. MAGMa’s utility was validated on benchmarking datasets, where it consistently outperformed existing methods in identifying accurate interaction signals. MAGMa was applied to disease models with high therapeutic relevance, including SARS-CoV-2 and onco-fusion-driven cancers. In SARS-CoV-2 studies, MAGMa revealed a detailed host-pathogen interactome by identifying novel viral-host protein interactions. This approach led to the discovery of potential antiviral targets, with the drug carvedilol demonstrating promising antiviral effects in follow-up studies. In cancer models, MAGMa enabled us to dissect the altered protein interaction networks driven by oncogenic fusion proteins, identifying critical perturbations in the SWI/SNF chromatin remodeling complex in sarcoma. These findings shed light on the molecular underpinnings of fusion-mediated oncogenesis and open avenues for targeted cancer therapies. This corpus of work explores how network dynamics inform disease progression and the potential for computational tools to refine protein biomarkers as close phenotypic readouts. Results presented herein demonstrate how rigorous statistical methods can enhance the precision of proteomic analyses, making it possible to unravel complex biological interactions and prioritize drug targets. MAGMa provides researchers with a powerful tool to deepen insights into disease mechanisms and accelerate therapeutic discovery across a range of pathologies.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso">en</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Host-Pathogen Interactome</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Onco-fusion-driven Cancers</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Protein Interaction Networks</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Quantitative Proteomics</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Statistical Testing</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Therapeutic Discovery</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">Mass spectrometry based proteomics and its applications in understanding disease progression and designing therapeutic strategies.</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">dissertation or thesis</dim:field>
   <dim:field mdschema="dc" element="relation" qualifier="localuri">https://newcatalog.library.cornell.edu/catalog/16921875</dim:field>
   <dim:field mdschema="dc" element="format" qualifier="mimetype">application/pdf</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="discipline">Computational Biology</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="grantor">Cornell University</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="level">Doctor of Philosophy</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="name">Ph. D., Computational Biology</dim:field>
   <dim:field mdschema="dcterms" element="license">https://hdl.handle.net/1813/59810.2</dim:field>
   <dim:field mdschema="dspace" element="entity" qualifier="type">Publication</dim:field>
   <dim:field mdschema="cris" element="virtual" qualifier="collection" authority="https://cornell-ecommons.eks.prod.4science.cloud/handle/1813/47" confidence="600">Cornell Theses and Dissertations</dim:field>
   <dim:field mdschema="cris" element="virtual" qualifier="author">Gupta, Shagun</dim:field>
   <dim:field mdschema="cris" element="virtualsource" qualifier="collection">5893a6ea-7af3-41d7-abc6-04bcd26ab5df</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
   <dim:field mdschema="cerif" element="openaire" authority="" confidence="-1">&lt;Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="336e4417-3a61-459e-af8b-2a9ac71d05fa">
	&lt;Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843&lt;/Type>
	&lt;Language>en&lt;/Language>
   	&lt;Title>Mass spectrometry based proteomics and its applications in understanding disease progression and designing therapeutic strategies.&lt;/Title>
   	&lt;PublishedIn>
    	&lt;Publication>
      	&lt;/Publication>
   	&lt;/PublishedIn>
   	&lt;PublicationDate>2024-12&lt;/PublicationDate>
   	&lt;DOI>http://doi.org/10.7298/77yj-8w97&lt;/DOI>
   	&lt;Authors>
      	&lt;Author>
        	&lt;DisplayName>Gupta, Shagun&lt;/DisplayName>
         	&lt;Affiliation>
         		&lt;OrgUnit>
         		&lt;/OrgUnit>
         	&lt;/Affiliation>
      	&lt;/Author>
	&lt;/Authors>
   	&lt;Editors>
	&lt;/Editors>
    &lt;Publishers>
        &lt;Publisher>
            &lt;OrgUnit />
        &lt;/Publisher>
    &lt;/Publishers>
    &lt;Keyword>Host-Pathogen Interactome&lt;/Keyword>
    &lt;Keyword>Onco-fusion-driven Cancers&lt;/Keyword>
    &lt;Keyword&gt;Protein Interaction Networks&lt;/Keyword>
    &lt;Keyword>Quantitative Proteomics&lt;/Keyword>
    &lt;Keyword>Statistical Testing&lt;/Keyword>
    &lt;Keyword>Therapeutic Discovery&lt;/Keyword>
   	&lt;Abstract>Quantitative proteomics offers transformative insights into molecular mechanisms underlying complex diseases; however, the inherent noise and variability in proteomic data pose significant challenges for accurate signal detection. This led to the development of the Maximal Aggregation of Good protein signal from Mass spectrometric data (MAGMa) tool, which leverages rigorous statistical testing to achieve a balance between sensitivity and specificity, effectively filtering out noise and enabling robust identification of subtle, true biological signals. MAGMa’s utility was validated on benchmarking datasets, where it consistently outperformed existing methods in identifying accurate interaction signals. MAGMa was applied to disease models with high therapeutic relevance, including SARS-CoV-2 and onco-fusion-driven cancers. In SARS-CoV-2 studies, MAGMa revealed a detailed host-pathogen interactome by identifying novel viral-host protein interactions. This approach led to the discovery of potential antiviral targets, with the drug carvedilol demonstrating promising antiviral effects in follow-up studies. In cancer models, MAGMa enabled us to dissect the altered protein interaction networks driven by oncogenic fusion proteins, identifying critical perturbations in the SWI/SNF chromatin remodeling complex in sarcoma. These findings shed light on the molecular underpinnings of fusion-mediated oncogenesis and open avenues for targeted cancer therapies. This corpus of work explores how network dynamics inform disease progression and the potential for computational tools to refine protein biomarkers as close phenotypic readouts. Results presented herein demonstrate how rigorous statistical methods can enhance the precision of proteomic analyses, making it possible to unravel complex biological interactions and prioritize drug targets. MAGMa provides researchers with a powerful tool to deepen insights into disease mechanisms and accelerate therapeutic discovery across a range of pathologies.&lt;/Abstract>
	&lt;Access xmlns="http://purl.org/coar/access_right" 
    >
    &lt;/Access>
&lt;/Publication>
</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>